1-14 of 14
direct oral anticoagulants
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America

Ignacio Neumann, Ariel Izcovich, Ricardo Aguilar, Guillermo León Basantes, Patricia Casais, Cecilia C. Colorio, María Cecilia Guillermo Esposito, Pedro P. García Lázaro, Luis A. Meillon-García, Jaime Pereira, Suely Meireles Rezende, Juan Carlos Serrano, Mario L. Tejerina Valle, Felipe Vera, Lorena Karzulovic, Gabriel Rada, Holger Schünemann
Journal: Blood Advances
Blood Adv (2021) 5 (15): 3032–3046.
https://doi.org/10.1182/bloodadvances.2021004267
Published: 2021
Includes: Supplemental data
Journal Articles

Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry

Clinical Trials & Observations
Jean-Pierre Bassand, Saverio Virdone, Marc Badoz, Freek W. A. Verheugt, A. John Camm, Frank Cools, Keith A. A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Frank Misselwitz, Karen S. Pieper, Alexander G. G. Turpie, Martin van Eickels, Ajay K. Kakkar
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1081–1091.
https://doi.org/10.1182/bloodadvances.2020003560
Published: 2021
Includes: Supplemental data
Journal Articles

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

Clinical Trials & Observations
Gary H. Lyman, Marc Carrier, Cihan Ay, Marcello Di Nisio, Lisa K. Hicks, Alok A. Khorana, Andrew D. Leavitt, Agnes Y. Y. Lee, Fergus Macbeth, Rebecca L. Morgan, Simon Noble, Elizabeth A. Sexton, David Stenehjem, Wojtek Wiercioch, Lara A. Kahale, Pablo Alonso-Coello
Journal: Blood Advances
Blood Adv (2021) 5 (4): 927–974.
https://doi.org/10.1182/bloodadvances.2020003442
Published: 2021
Includes: Supplemental data
Journal Articles

Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism

Clinical Trials & Observations
Olivia S. Costa, Christine G. Kohn, Nicole M. Kuderer, Gary H. Lyman, Thomas J. Bunz, Craig I. Coleman
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4045–4051.
https://doi.org/10.1182/bloodadvances.2020002242
Published: 2020
Journal Articles

An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms

Annette von Drygalski, Vikas Bhat, Andrew J. Gale, Patricia M. Averell, Thomas J. Cramer, Darlene J. Elias, John H. Griffin, Laurent O. Mosnier
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3716–3727.
https://doi.org/10.1182/bloodadvances.2020001699
Published: 2020
Includes: Supplemental data
Journal Articles

Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure

Clinical Trials & Observations
Joseph R. Shaw, Na Li, Thomas Vanassche, Michiel Coppens, Alex C. Spyropoulos, Summer Syed, Mansoor Radwi, Joanne Duncan, Sam Schulman, James D. Douketis
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3520–3527.
https://doi.org/10.1182/bloodadvances.2020002335
Published: 2020
Includes: Supplemental data
Journal Articles

DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines

Ignacio Neumann, Ariel Izcovich, Yuqing Zhang, Gabriel Rada, Susan R. Kahn, Frederick Spencer, Suely Rezende, Franchesco Dentali, Kenneth Bauer, Gian Paolo Morgano, Juan J. Yepes-Nuñez, Robby Nieuwlaat, Wojtek Wiercioch, Liming Lu, Jiaming Wu, Mary Cushman, Holger Schunemann
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1512–1517.
https://doi.org/10.1182/bloodadvances.2019000840
Published: 2020
Includes: Supplemental data
Journal Articles

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis

Clinical Trials & Observations
Leonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Kevin Troy, Thomas Schiano, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (4): 655–666.
https://doi.org/10.1182/bloodadvances.2019001310
Published: 2020
Journal Articles

Managing patients who are receiving warfarin or a direct oral anticoagulant and need an elective surgery or procedure

James Douketis, Andrea Cervi
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1925.
https://doi.org/10.1182/bloodadvances.2019000171
Published: 2019
Includes: Supplemental data
Journal Articles

A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation

Clinical Trials & Observations
Miney Paquette, Daniel M. Witt, Anne Holbrook, Jane Skov, Jack Ansell, Holger J. Schünemann, Wojtek Wiercioch, Robby Nieuwlaat
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1638–1646.
https://doi.org/10.1182/bloodadvances.2019000067
Published: 2019
Includes: Supplemental data
Journal Articles

Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors

Manu T. Kalathottukaren, A. Louise Creagh, Srinivas Abbina, Genmin Lu, Mark J. Karbarz, Anjali Pandey, Pamela B. Conley, Jayachandran N. Kizhakkedathu, Charles Haynes
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2104–2114.
https://doi.org/10.1182/bloodadvances.2016003616
Published: 2018
Includes: Supplemental data
Journal Articles

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Clinical Trials & Observations
Surbhi Shah, Faye L. Norby, Yvonne H. Datta, Pamela L. Lutsey, Richard F. MacLehose, Lin Y. Chen, Alvaro Alonso
Journal: Blood Advances
Blood Adv (2018) 2 (3): 200–209.
https://doi.org/10.1182/bloodadvances.2017010694
Published: 2018
Includes: Supplemental data
Journal Articles

Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants

Clinical Trials & Observations
Jordan K. Schaefer, Suman L. Sood, Brian Haymart, Xiaokui Gu, Xiaowen Kong, Eva Kline-Rogers, Steven Almany, Jay Kozlowski, Gregory D. Krol, Scott Kaatz, James B. Froehlich, Geoffrey D. Barnes
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2536–2540.
https://doi.org/10.1182/bloodadvances.2017012377
Published: 2017
Journal Articles

The direct oral anticoagulants: can we finally stop using rat poison?

Mark Crowther
Journal: Blood Advances
Blood Adv (2017) 1 (14): 980.
https://doi.org/10.1182/bloodadvances.2017002907
Published: 2017
Includes: Supplemental data